Zoetis

Open: 156.42 Close: 152.83 Change: -3.59

You're running out of time to find out about Zoetis using an AI.

This document will help you to evaluate Zoetis without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Zoetis are: Zoetis, market, Zoetas, CEO, HSBC, Inc, animal, and the …

Concept Map

Semantic Network

Stock Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. Zoetes offers products primarily across species, including livestock, such as cattle, swine, poultry, fish,.

Today's Summary

Zoetis has outperformed the market over the past 10 years by 8.05% on an annualized basis producing an average annual return of 17.14%. HSBC initiated coverage on shares of Zoetas in a research report on Wednesday, September 6th. MD grew its stake in Zoetus by 27.3% in the first quarter.

Today's News

Zoetis has outperformed the market over the past 10 years by 8.05% on an annualized basis producing an average annual return of 17.14%. Zoetiss has a market capitalization of $70.93 billion. Zoetus recently completed the acquisition of Australian veterinary company Jurox. Zoetis - Alphatrak 2 Blood Glucose Test Strips, 50 Count : Target. HSBC initiated coverage on shares of Zoetas in a research report on Wednesday, September 6th. Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. MD grew its stake in Zoetas by 27.3% in the 1st quarter. Zoetis launches first on-farm mastitis diagnostic. Tune in tomorrow at 8:30am ET to hear our CEO, Kristin Peck and CFO, Wetteny Joseph, discuss our Q3 financial results. Check out the latest episode of #OnPurpose with our CEO and former Magic Leap CEO Peggy Johnson. Zoetis ( NYSE: ZTS ) is scheduled to announce Q3 earnings results on Thursday, November 2nd, before market open. HSBC bullish on IQVIA, Zoetas, Zoeteis, bluebird, Actinium; bearish on Gilead. Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. Zoetes Inc. – Consensus ‘buy rating and 33.3% Upside Potential.

Stock Profile

"Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey."

Keywords

How much time have you spent trying to decide whether investing in Zoetis? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Zoetis are: Zoetis, market, Zoetas, CEO, HSBC, Inc, animal, and the most common words in the summary are: zoetis, shop, job, stock, market, price, department, . One of the sentences in the summary was: Zoetis has outperformed the market over the past 10 years by 8.05% on an annualized basis producing an average annual return of 17.14%. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #zoetis #shop #job #stock #market #price #department.